{"DataElement":{"publicId":"3653021","version":"1","preferredName":"Medication COX-2 Inhibitor Use Twice Weekly Duration","preferredDefinition":"A manner, or usual, or accepted practice of using a subgroup of non-steroidal anti-inflammatory drugs (NSAID) that specifically targets at cyclooxygenase 2, an enzyme involved in pain and inflammation._Two times per week._The period of time during which something continues.","longName":"3379228v1.0:3651416v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3379228","version":"1","preferredName":"Medication COX-2 Inhibitor Use","preferredDefinition":"A manner, or usual, or accepted practice of using a subgroup of non-steroidal anti-inflammatory drugs (NSAID) that specifically targets at cyclooxygenase 2, an enzyme involved in pain and inflammation.","longName":"2411879v1.0:3379226v1.0","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"2411879","version":"1","preferredName":"Medication","preferredDefinition":"biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.","longName":"C459","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"019C7266-B896-0AAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-27","modifiedBy":"ONEDATA","dateModified":"2005-09-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3379226","version":"1","preferredName":"COX-2 Inhibitor Use","preferredDefinition":"A subgroup of non-steroidal anti-inflammatory drugs (NSAID) that specifically targets at cyclooxygenase 2, an enzyme involved in pain and inflammation.:A manner, or usual, or accepted practice of using something.","longName":"C80509:C25340","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"COX-2 Inhibitor","conceptCode":"C80509","definition":"A subgroup of non-steroidal anti-inflammatory drugs (NSAID) that specifically targets at cyclooxygenase 2, an enzyme involved in pain and inflammation.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B918227F-B35B-6EA7-E040-BB89AD434A76","latestVersionIndicator":"Yes","beginDate":"2012-02-16","endDate":null,"createdBy":"SCOTTM","dateCreated":"2012-02-16","modifiedBy":"ONEDATA","dateModified":"2012-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008558","version":"1","preferredName":"Units of Measure","preferredDefinition":"the units of measure for assessment results and dosing.","longName":"UOM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2DECB93-42CA-248A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-28","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B918227F-B36C-6EA7-E040-BB89AD434A76","latestVersionIndicator":"Yes","beginDate":"2012-02-16","endDate":null,"createdBy":"SCOTTM","dateCreated":"2012-02-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"5/16/13 jc moved to SWOG context.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3651416","version":"1","preferredName":"Twice Weekly Duration","preferredDefinition":"Two times per week._The period of time during which something continues.","longName":"3651416v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2513925","version":"1","preferredName":"Activity","preferredDefinition":"An action taken in pursuit of an objective; the state of being active.","longName":"C43431","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8A8A1E-77BA-4685-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-08-21","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3651415","version":"1","preferredName":"Twice Weekly Duration","preferredDefinition":"Two times per week.:The period of time during which something continues.","longName":"C64497:C25330","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Twice Weekly","conceptCode":"C64497","definition":"Two times per week.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Duration","conceptCode":"C25330","definition":"The period of time during which something continues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30655D0-F239-82DB-E040-BB89AD435C17","latestVersionIndicator":"Yes","beginDate":"2013-01-11","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-01-11","modifiedBy":"ONEDATA","dateModified":"2013-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30655D0-F24A-82DB-E040-BB89AD435C17","latestVersionIndicator":"Yes","beginDate":"2013-01-11","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-01-11","modifiedBy":"CHILLIJ","dateModified":"2014-07-22","changeDescription":"7/22/14 CDE released; VD released per Christine Rodgers. jc    1/11/13 created for UAMS cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3029677","version":"1","longName":"UAMS Clinical Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812848","version":"1","longName":"UAMS New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"In total, for how long have y","type":"Preferred Question Text","description":"In total, for how long have you ever taken Cox-2 inhibitor medications at least 2 times per week?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D37DAEC3-AA12-8744-E040-BB89AD436788","latestVersionIndicator":"Yes","beginDate":"2013-01-17","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-01-17","modifiedBy":"RODGERSC","dateModified":"2015-02-25","changeDescription":"created for UAMS cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}